• Zakiah Mohd Said Community Health Department, Medical Faculty, University Kebangsaan Malaysia,Jln Yaakob Latif Bandar Tun Razak, 56000 Cheras Kuala Lumpur, Malaysia
  • Rosnah Sutan Community Health Department, Medical Faculty, University Kebangsaan Malaysia,Jln Yaakob Latif Bandar Tun Razak, 56000 Cheras Kuala Lumpur, Malaysia
Keywords: breast cancer, screening, policy, empowerment


Breast cancer is the most common cancer affecting  women globally. Several ways of breast cancer screening tools are available. This study aims to evaluate Malaysia's breast cancer screening program using the national database based on participation and performance indicators for the past five years. A retrospective cumulative analysis of clinical breast examination and mammogram screening services were performed using the national dataset of 2016-2020 obtained from the Health Informatics Centres, Ministry of Health Malaysia. The performance indicator represents the percentage of breast abnormality detected during clinical breast examination and the proportion of confirmed cancer through mammogram screening.  A reduction in the participation rate for clinical breast examination was noted from 2016 (25.8%) to 2020(25.1%). However, a high participation rate in 2019 (29.1%) was noted following active health promotion intervention. The rate of high-risk women who underwent mammogram screening fluctuated by years according to active breast awareness campaign. The average rate of confirmed breast cancer annually was 0.7% and was noted highest in 2020 (1.17%).  Improving early diagnosis is an eminent strategy for cancer control in all settings, including strengthening health systems and providing universal health coverage. Successful breast cancer prevention and control programs require intersectoral planning and active community participation. Ensuring sustainability and accessibility of breast cancer screening programs is highly needed. Fostering good collaborative multiagency partnership and community participation for the cancer control program urges an innovative approach through a policy formulation.


Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153–6. doi: 10.1002/ijc.1440. PMID: 11668491.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 ;caac.21660.

Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? J Glob Oncol. 2018 ;4:1-16. doi: 10.1200/JGO.17.00207. PMID: 30085889; PMCID: PMC6223528.

da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics (Sao Paulo). 2017;72(4):244-253. doi: 10.6061/clinics/2017(04)09. PMID: 28492725; PMCID: PMC5401614.

National Cancer Institute Ministry of HealthMalaysia. National Cancer Registry Report 2012-2016.June 2019. ISBN: 978-967-16142-2-8

Norsa'adah B, Rahmah MA, Rampal KG, Knight A. Understanding barriers to Malaysian women with breast cancer seeking help. Asian Pac J Cancer Prev. 2012;13(8):3723-30. doi: 10.7314/apjcp.2012.13.8.3723. PMID: 23098462.U

Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer Screening — Viewpoint of the IARC Working Group. N Engl J Med. 2015 ;372(24):2353–8. Available from:

Bleyer A, Welch HG. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence. N Engl J Med 2012;367(21):1998–2005. DOI:10.1056/NEJMoa1206809

Pape R, Spuur KM, Umo P. Factors contributing to low participation in mammography screening in Papua New Guinea. Radiography 22(2016) e151-e158.

Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445-57. doi: 10.1093/jnci/94.19.1445. PMID: 12359854.

Semiglazov VF, Sagaidak VN, Moiseyenko VM, Mikhailov EA. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer. 1993;29A(14):2039-46. PMID: 8280499.

Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ; Clinical Guidelines Committee of the American College of Physicians, Forciea MA, Fitterman N, Iorio A, Kansagara D, Maroto M, McLean RM, Tufte JE, Vijan S. Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians. Ann Intern Med. 2019;170(8):547-560. doi: 10.7326/M18-2147. Epub 2019 Apr 9. PMID: 30959525.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017;14(9):1137–43.

Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021 Feb 24;372:n256. doi: 10.1136/bmj.n256. Erratum in: BMJ. 2021 Mar 19;372:n738. PMID: 33627312; PMCID: PMC7903383.

World Health Organization.WHO position paper on mammography screening. ISBN 978 92 4 150793 6;

Family Health Development Division. Adult health.

Malaysian Health Technology Assessment Section (MaHTAS). Management of Breast Cancer (Third Edition). ISBN: 978-967-2173-99-1 .

Family Health Development Division.Annual report 2018.ISSN 1511-1512.

Mukem S, Meng Q, Sriplung H, Tangcharoensathien V. Low coverage and disparities of breast and cervical cancer screening in Thai women: Analysis of national representative household surveys. Asian Pacific J Cancer Prev. 2016;16(18):8541–51.

Maznah D, Sofea R, Awang B. Breast Cancer Prevention and Control Programs in Malaysia. Asian Pacific journal of cancer prevention: 2011, 12(6):1631-4

Norlaili AA, Fatihah MA, Daliana NF, Maznah D. Breast cancer awareness of rural women in Malaysia: is it the same as in the cities? Asian Pac J Cancer Prev. 2013;14(12):7161-4. doi: 10.7314/apjcp.2013.14.12.7161. PMID: 24460269.

Provencher L, Hogue JC, Desbiens C, Poirier B, Poirier E, Boudreau D, et al. Is clinical breast examination important for breast cancer detection? Curr Oncol 2016;23(4):e332–9. Available from: /pmc/articles/PMC4974039/

Mukem S, Sriplung H, McNeil E, Tangcharoensathien V. Breast cancer screening among women in Thailand: analyses of population-based household surveys. J Med Assoc Thai. 2014 ;97(11):1106-18. PMID: 25675674.(

Loy EY, Molinar D, Chow KY, Fock C. National Breast Cancer Screening Programme, Singapore: evaluation of participation and performance indicators. J Med Screen. 2015 ;22(4):194-200. doi: 10.1177/0969141315589644. Epub 2015 Jun 16. PMID: 26081449.L

Mahmud A, Aljunid SM. Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach. PLoS ONE 2018;13(2): e0191764.

Mahmud A, Aljunid SM. The uptake of Mammogram screening in Malaysia and its associated factors: A systematic review. Med J Malaysia 2018;73 (4):2018

Rahmah MA, Aniza I, Che Engku Nor Bahiyah CE. Do elderly women in Malaysia go for mammogram screening? Malaysian Journal of PublicHealth Medicine 2013; 519: 79-6

Liberman L, Dershaw DD, Deutch BM, Thaler HT, Lippin BS. Screening mammography: value in women 35-39 years old.;161(1):53–6.

Sutan R. Urbanisation Challenge: Conceptual Framework Alignment in Family Health

Improvement- Process Needs. Med J Malaysia 2019; 74 (Supl 2):2019.

Sutan R, Siregar PP. Access To Reproductive Health Services Among Migrant Indonesian Female Workers In Peninsular Malaysia. Malaysian Journal of Public Health Medicine, 21(2), 449-456.

How to Cite